Extent of eosinophilic esophagitis predicts response to treatment

 

 Lizenzen und Reprints

Abstract

Background and study aim The clinical impact of eosinophilic esophagitis (EoE) limited to the distal esophagus (Lim-EE) vs. diffuse involvement (Dif-EE) is unknown. This study compared clinical characteristics and outcomes of Lim-EE vs. Dif-EE.

Patients and methods This retrospective, single-center study of patients with EoE between December 2011 and December 2019 evaluated treatment response based on repeated pathology and/or clinical improvement using comparative statistics.

Results 479 patients were identified (126 Lim-EE, 353 Dif-EE). Lim-EE patients had a higher incidence of endoscopically identified esophagitis (23.0 % vs. 14.7 %; P = 0.04), were older (50.8 [SD 16.2] vs. 46.4 [SD 15.3] years; P = 0.007), and were more likely to present with iron deficiency anemia (5.6 % vs. 1.7 %; P = 0.05), dyspepsia (15.1 % vs. 8.8 %; P = 0.06) or for Barrett’s surveillance (10.3 % vs. 3.7 %; P = 0.02). Patients with Dif-EE presented more frequently with dysphagia (57.2 % vs. 45.2 %; P = 0.02). Both groups had similar proton pump inhibitor (87.2 % vs. 83.3 %; P = 0.37) and steroid (12.8 % vs. 21.4 %; P = 0.14) use. Patients with Lim-EE had a better clinicopathologic response (61.5 % vs. 44.8 %; P = 0.009). On multivariate analysis, EoE extent predicted treatment response with an odds ratio of 1.89 (95 % confidence interval 1.13–3.20; P = 0.02). However, treatment response based only on repeat biopsy results showed no statistical difference between Lim-EE (52.5 %) and Dif-EE (39.7 %; P = 0.15).

Conclusions Lim-EE may represent a distinct phenotype separate from Dif-EE, with more overlap with gastroesophageal reflux disease and better treatment response.

Publikationsverlauf

Eingereicht: 18. November 2020

Angenommen: 15. März 2021

Artikel online veröffentlicht:
16. Juli 2021

© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Dellon ES, Hirano I. Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology 2018; 154: 319-332
  CrossrefPubMedGoogle Scholar
• 2 Dellon ES. Approach to diagnosis of eosinophilic esophagitis. Gastroenterol Hepatol (N Y) 2011; 7: 742-744
  PubMedGoogle Scholar
• 3 Dellon ES, Gonsalves N, Hirano I. et al. ACG Clinical Guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol 2013; 108: 679-692
  CrossrefPubMedGoogle Scholar
• 4 Lucendo AJ, Molina-Infante J, Arias A. et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United European Gastroenterol J 2017; 5: 335-358
  CrossrefPubMedGoogle Scholar
• 5 Gonsalves N, Policarpio-Nicolas M, Zhang Q. et al. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc 2006; 64: 313-319
  CrossrefPubMedGoogle Scholar
• 6 Spechler SJ. Gastroesophageal reflux disease and eosinophilic esophagitis. Gastroenterol Hepatol (N Y) 2019; 15: 111-113
  PubMedGoogle Scholar
• 7 Lee S, de Boer WB, Naran A. et al. More than just counting eosinophils: proximal oesophageal involvement and subepithelial sclerosis are major diagnostic criteria for eosinophilic oesophagitis. J Clin Pathol 2010; 63: 644-647
  CrossrefPubMedGoogle Scholar
• 8 Alkhattabi M, Kubica M, Driman D. et al. A225 The utility of separate distal and mid-esophageal biopsies in the diagnosis of eosinophilic esophagitis (EoE). J Can Assoc Gastroenterol 2018; 1: 392-393
  CrossrefPubMedGoogle Scholar
• 9 Molina-Infante J, Ferrando-Lamana L, Ripoll C. et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol 2011; 9: 110-117
  CrossrefPubMedGoogle Scholar
• 10 Liacouras CA, Furuta GT, Hirano I. et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128: 3-20
  CrossrefPubMedGoogle Scholar
• 11 Saffari H, Peterson KA, Fang JC. et al. Patchy eosinophil distributions in an esophagectomy specimen from a patient with eosinophilic esophagitis: implications for endoscopic biopsy. J Allergy Clin Immunol 2012; 130: 798-800
  CrossrefPubMedGoogle Scholar
• 12 Dellon ES, Liacouras CA, Molina-Infante J. et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference. Gastroenterology 2018; 155: 1022-1033
  CrossrefPubMedGoogle Scholar
• 13 Frazzoni M, Penagini R, Frazzoni L. et al. Role of reflux in the pathogenesis of eosinophilic esophagitis: comprehensive appraisal with off- and on PPI impedance-pH monitoring. Am J Gastroenterol 2019; 114: 1606-1613
  CrossrefPubMedGoogle Scholar
• 14 Winter HS, Madara JL, Stafford RJ. et al. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology 1982; 83: 818-823
  CrossrefPubMedGoogle Scholar
• 15 Rodrigo S, Abboud G, Oh D. et al. High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults. Am J Gastroenterol 2008; 103: 435-442
  CrossrefPubMedGoogle Scholar
• 16 Sayej WN, Patel R, Baker RD. et al. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2009; 49: 393-399
  CrossrefPubMedGoogle Scholar
• 17 Spechler SJ, Genta RM, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol 2007; 102: 1301-1306
  CrossrefPubMedGoogle Scholar
• 18 Shah NA, Albert DM, Hall NM. et al. Managing eosinophilic esophagitis: challenges and solutions. Clin Exp Gastroenterol 2016; 9: 281-290
  CrossrefPubMedGoogle Scholar
• 19 Gomez-Aldana A, Jaramillo-Santos M, Delgado A. et al. Eosinophilic esophagitis: current concepts in diagnosis and treatment. World J Gastroenterol 2019; 25: 4598-4613
  CrossrefPubMedGoogle Scholar
• 20 Lucendo AJ, Arias A, Molina-Infante J. Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2016; 14: 13-22
  CrossrefPubMedGoogle Scholar
• 21 Gomez-Torrijos E, Garcia-Rodriguez R, Castro-Jimenez A. et al. The efficacy of step-down therapy in adult patients with proton pump inhibitor-responsive oesophageal eosinophilia. Aliment Pharmacol Ther 2016; 43: 534-540
  CrossrefPubMedGoogle Scholar
• 22 Lucendo AJ, Miehlke S, Schlag C. et al. Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial. Gastroenterology 2019; 157: 74-86
  CrossrefPubMedGoogle Scholar
• 23 Eluri S, Dellon ES. Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences. Curr Opin Gastroenterol 2015; 31: 309-315
  CrossrefPubMedGoogle Scholar
• 24 Sawada A, Hashimoto A, Uemura R. et al. Association between endoscopic findings of eosinophilic esophagitis and responsiveness to proton pump inhibitors. Endosc Int Open 2019; 7: E433-E439
  Artikel in Thieme ConnectPubMedGoogle Scholar

• Zusatzmaterial